{
    "title": "Regeneron says COVID-19 antibody cocktail may be available by fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8288355/Regeneron-Pharma-beats-quarterly-estimates-Eylea-strength.html",
    "date": "2020-05-05",
    "keywords": [
        "regeneron",
        "antibody",
        "cocktail",
        "covid19",
        "end",
        "summer",
        "drug",
        "demand",
        "joseph",
        "roy",
        "tuesday",
        "fall",
        "coronavirus",
        "treatment",
        "month",
        "lot",
        "disease",
        "eye",
        "eylea",
        "outbreak",
        "quarter",
        "share",
        "revenue",
        "use",
        "june",
        "company",
        "vaccine",
        "aim",
        "manufacturing",
        "companys",
        "morning",
        "trade",
        "hope",
        "cofounder",
        "officer",
        "george",
        "conference",
        "call",
        "reality",
        "drugmaker",
        "effectiveness",
        "infection",
        "kevzara",
        "theory",
        "overreaction",
        "bodys",
        "immune",
        "system",
        "respiratory",
        "distress",
        "profit",
        "blockbuster",
        "impact",
        "spread",
        "hospital",
        "lucentis",
        "novartis",
        "roche",
        "decline",
        "hit",
        "rebound",
        "average",
        "refinitiv",
        "reporting",
        "sibi",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}